BiPAP呼吸机联合回苏灵治疗COPD急性加重期合并Ⅱ型呼吸衰竭的临床疗效分析

Curative Effect of BiPAP Ventilator Combined Dimefline in the Treatment of COPD with Type Ⅱ Respiratory Failure

目的:探讨BiPAP呼吸机联合回苏灵治疗COPD急性加重期合并Ⅱ型呼吸衰竭的临床疗效。方法:将86例COPD急性加重期合并Ⅱ型呼吸衰竭患者分成治疗组43例和对照组43例,对照组给予抗感染、解痉平喘、止咳化痰、低流量输氧等常规治疗,治疗组除常规治疗外,还加用BiPAP呼吸机辅助通气联合回苏灵治疗,观察两组患者治疗前后的HR、RR、pH、PaO2、PaCO2等指标变化。结果:治疗后两组HR、RR、pH、PaO2、PaCO2等指标改善程度均优于治疗前(P<0.01)。与对照组治疗后比较,治疗组治疗后HR、RR、pH、PaO2、PaCO2等改善程度明显优于对照组(P<0.05)。结论:BiPAP呼吸机联合回苏灵治疗COPD急性加重期合并Ⅱ型呼吸衰竭的临床疗效确切,病死率明显降低。

Objective： To investigate the BiPAP Ventilator combined dimcfline curative effect on the treatment of COPD patients with type Ⅱ respiratory failure. Method： 86 patients with acute exacerbation of COPD with type II respiratory failure patients were divided into treatment group （ 43 cases ） and control group （ 43 cases ）, control group were given anti-infection, spasmolysis, relieving cough and phlegm, low flow oxygen and other conventional treatment, the treatment group in addition to conventional treatment, added suction machine auxiliary ventilation combined with back Su Ling treatment with BiPAP call, the changes of the two groups before and after treatment in patients with HR, RR, pH, PaO2, PaCO2 index were observed. Result： After the treatment, two groups of HR, RR, pH, PaO2, PaCO2 and other indexes were more improved than that before treatment （ P〈0.01 ） . Compared with the control group, the treatment group after treatment HR, RR, pH, PaO2, PaCO2 improvement degree were significantly better than the control group （ P〈0.05 ） . Conclusion： BiPAP combine with clinical efficacy of ventilator Su Ling in the treatment of acute exacerbation of COPD with type II respiratory failure is exact, significantly reduced mortality.